Carnosine inhibits degradation of hyaluronan induced by free radical processes in vitro and improves the redox imbalance in adjuvant arthritis in vivo

Neuroendocrinology Letters

Volumn 31, Issue SUPPL. 2, 2010, Pages 96-100

  Dráfi, František ^a   Bauerová, Katarína ^a   Valachová, Katarína ^a   Poništ, Silvester ^a   Mihalová, Danica ^a   Juránek, Ivo ^a   Boldyrev, Alexander ^c   Hrabárova, Eva ^b   Šoltés, Ladislav ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

^c RESEARCH CENTER OF NEUROLOGY   (Russian Federation)

Author keywords

Arthritis; DMARDs; GSH; Methotrexate; Protein carbonyls; Rotational viscometry; TBARS; Weissberger's oxidative system

Indexed keywords

CARNOSINE; FREE RADICAL; GLUTATHIONE; HYALURONIC ACID; METHOTREXATE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADJUVANT ARTHRITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG DEGRADATION; DRUG EFFICACY; DRUG INHIBITION; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PROTEIN CARBONYLATION; RAT; VISCOMETRY; VISCOSITY;

EID: 79952810640     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bauerova K, Bezek Š (1999). Role of reactive oxygen and nitrogen species in etiopathogenesis of rheumatoid arthritis. Gen. Physiol. Biophys. 18: 15-20.
2. Bauerova K, Ponist S, Navarova J, Dubnickova M, Paulovicova E, Pajtinka M, Kogan G, Mihalova D (2008). Glucomannan in prevention of oxidative stress and inflammation occurring in adjuvant arthritis. Neuro Endocrinol. Lett. 29: 691-696.
3. Bauerova K, Paulovicova E, Mihalova D, Svik K, Ponist S (2009). Study of new ways of supplementary and combinatory therapy of rheumatoid arthritis with immunomodulators. Glucomannan and Imunoglukan in adjuvant arthritis. Toxicol Ind Health 25: 329-335.
4. Bauerova K, Paulovicova E, Mihalova D, Drafi F, Strosova M, Mascia C, Biasi F, Rovensky J, Kucharska J, Gvozdjakova A, Ponist S (2010). Combined methotrexate and coenzyme Q10 therapy in adjuvant-induced arthritis evaluated by using parameters of inflammation and oxidative stress. Acta Biochim. Pol. 57: 347-354.
5. Bohanec GP, Logar D, Tomsic M, Rozman B, Dolzan V (2009). Genetic polymorphisms modifying oxidative stress are associated with disease activity in rheumatoid arthritis patients. Dis. Markers 26: 41-48.
6. Boldyrev A (2005). Protection of Proteins from Oxidative Stress A New Illusion or a Novel Strategy? Ann. N. Y. Acad. Sci. 1057: 193-205.
7. Chan ESL, Cronstein BN (2002). Molecular action of methotrexate in inflammatory diseases. Arthritis Res. 4: 266-273. (Pubitemid 34716307)
8. Firestein GS (2003). Evolving concepts of rheumatoid arthritis. Nature 423: 356-361.
9. Ponist S, Mihalova D, Jancinova V, Snirc V, Ondrejickova O, Mascia C, Poli G, Stancikova M, Nosal R, Bauerova K (2010). Reduction of oxidative stress in adjuvant arthritis. Comparison of efficacy of two pyridoindoles: stobadine dipalmitate and SMe1.2HCI. Acta Biochim. Pol. 57: 223-228.
10. Kunsch C, Sikorski JA, Sundell CL (2005). Oxidative stress and the use of antioxidants for the treatment of rheumatoid arthritis. Curr Med Chem Immunol Endocr Metab Agents 5: 249-258. (Pubitemid 40908982)
11. Soltes L, Stankovska M, Kogan G, Gemeiner P, Stern R (2005). Contribution of oxidative-reductive reactions to high-molar-weight hyaluronan catabolism. Chem. Biodivers. 2: 1242-1245.
12. nd edition. New York: Nova Science Publishers. p. 181-199.
13. Valachova K, Rapta P, Kogan G, Hrabarova E, Gemeiner P, Soltes L (2009). Degradation of High-Molar-Mass Hyaluronan by Ascorbate plus Cupric Ions: Effects of D-Penicillamine Addition. Chem. Biodivers. 6: 389-395.
14. Valachova K, Rapta P, Hrabarova E, Drafi F, Bauerova K, Juranek I, Soltes L (2010). Aurothiomalate in function of preventive and chain-breaking antioxidant at radical degradation of high-molar-mass hyaluronan. Chem. Biodivers. submitted
15. Wessels JAM, Huizinga TWJ and Guchelaar HJ (2008). Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis. Rheumatology 47: 249-255. (Pubitemid 351267187)
16. Yamazaki K, Fukuda K, Matsukawa M, Hara F, Yoshida K, Akagi M, Munakata H, Hamanishi C (2003). Reactive oxygen species depolymerize hyaluronan: involvement of the hydroxyl radical. Pathophysiology 9: 215-220. (Pubitemid 37297866)